Elo Mutual Pension Insurance Co lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,429 shares of the medical equipment provider's stock after selling 1,281 shares during the period. Elo Mutual Pension Insurance Co's holdings in Intuitive Surgical were worth $16,927,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in ISRG. Bennett Selby Investments LP boosted its stake in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after buying an additional 17 shares during the period. Onefund LLC raised its holdings in shares of Intuitive Surgical by 1.9% during the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after acquiring an additional 18 shares in the last quarter. LVW Advisors LLC boosted its position in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after purchasing an additional 19 shares during the last quarter. Wesbanco Bank Inc. grew its stake in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after purchasing an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC increased its position in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock worth $542,000 after purchasing an additional 19 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.
Insiders Place Their Bets
In other Intuitive Surgical news, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now directly owns 473 shares of the company's stock, valued at approximately $271,397.94. The trade was a 63.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last 90 days. Corporate insiders own 0.70% of the company's stock.
Intuitive Surgical Stock Down 0.6 %
Shares of ISRG stock traded down $2.73 during mid-day trading on Monday, reaching $489.12. The stock had a trading volume of 678,267 shares, compared to its average volume of 1,523,849. The firm has a market cap of $174.21 billion, a PE ratio of 76.41, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm's 50 day simple moving average is $556.28 and its 200 day simple moving average is $532.97.
Analyst Upgrades and Downgrades
Several analysts have commented on the stock. Robert W. Baird decreased their target price on shares of Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating for the company in a research report on Tuesday, March 18th. Barclays lifted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Raymond James increased their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Bernstein Bank boosted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. Finally, Stifel Nicolaus raised their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average price target of $611.86.
Read Our Latest Stock Analysis on ISRG
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.